In the US, severe corona patients have been banned from testing if they did not benefit after thinning blood. The National Institutes of Health (NIH) said in a press release issued here on Tuesday, "Corona's critical patients require intensive care unit (ICU) support. Blood thinning clinical medicine is not effective in reducing the association of body parts. ”
The NIH stated that enrollment and testing for moderately ill hospitalized Kovid patients will continue. Because researchers have yet to prescribe a favorable dose to prevent blood clots, which is a common problem. The release states that abnormal clots can cause a number of health complications, including lung damage, heart attack and stroke.